Bendamustine hydrochloride monohydrateProduct ingredient for Bendamustine

Name
Bendamustine hydrochloride monohydrate
Drug Entry
Bendamustine

Bendamustine is a nitrogen mustard drug indicated for use in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Bendamustine is a bifunctional mechlorethamine derivative capable of forming electrophilic alkyl groups that covalently bond to other molecules. Through this function as an alkylating agent, bendamustine causes intra- and inter-strand crosslinks between DNA bases resulting in cell death. It is active against both active and quiescent cells, although the exact mechanism of action is unknown.

Accession Number
DBSALT003087
Structure
Synonyms
Not Available
UNII
X15906D285
CAS Number
1374784-02-7
Weight
Average: 412.74
Monoisotopic: 411.0883247
Chemical Formula
C16H24Cl3N3O3
InChI Key
TWBJYCLUHINEDN-UHFFFAOYSA-N
InChI
InChI=1S/C16H21Cl2N3O2.ClH.H2O/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23;;/h5-6,11H,2-4,7-10H2,1H3,(H,22,23);1H;1H2
IUPAC Name
4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid hydrate hydrochloride
SMILES
O.Cl.CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl
ChemSpider
32701457
Predicted Properties
PropertyValueSource
Water Solubility0.0618 mg/mLALOGPS
logP3.07ALOGPS
logP1.8Chemaxon
logS-3.8ALOGPS
pKa (Strongest Acidic)4.36Chemaxon
pKa (Strongest Basic)6.41Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area58.36 Å2Chemaxon
Rotatable Bond Count9Chemaxon
Refractivity92.92 m3·mol-1Chemaxon
Polarizability38.23 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon